UNSPSC 51453406: Bioallethrin

This classification denotes an insecticide with the molecular formula C19H26O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier G79DM7O471, chemically known as 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid, ester with 2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one but more generally known as bioallethrin, which bears U.S. NIH Compound Identifier 11442. Bioallethrin most often comes in base and s-cyclopentenyl forms.

European Medicines Agency schedules Bioallethrin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13071MIG. World Health Organization schedules bioallethrin in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51453406 Bioallethrin is a Commodity code that in recent state and local procurement appears largely misaligned with its nominal scope; the opportunities tagged to it involve naloxone, prescription pharmaceuticals, and medical and first aid supplies rather than bioallethrin (a pyrethroid insecticide). State and local governments procuring under this code are acquiring emergency medical products, pharmaceutical inventory, and health-related consumables through various issuing bodies — county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The work spans procurement of specific medical devices such as naloxone auto-injectors and drug deactivation systems; generic and OTC pharmaceuticals distributed through authorized wholesalers; and consumable medical supplies including respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, and bandaging materials for emergency response operations.

Recent activity concentrates in the South and Midwest, with documented solicitations from Florida, Texas, and Minnesota. Representative opportunities include Seminole County's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026; the City of Tampa's competitive bid 26P00145 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a March 13, 2026 response deadline (now closed); Texas HHS Commission's Request for Information HHS0017013 exploring direct-to-manufacturer prescription programs with an April 3, 2026 response date; and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, due March 26, 2026. The code shows little activity aligned with bioallethrin's actual commodity definition, suggesting either systematic miscoding in state and local systems or that bioallethrin procurement does not drive meaningful state and local solicitation volume under this designation.